Somatostatin-dopamine chimeric analogs, pharmaceutical compositions comprising such and the use thereof for the manufacture of medicaments for the treatment of disease.
SUMMARY A series of somatostatin-dopamine chimeric analogs with both somatostatin and dopamine activity in vivo have been described. An example is: 6-N-8β-ergolinmethylthioacetyl-D-Phe-c- (Cys-Tyr-D-Trp-LysAbu-Cys) -Thr-NH2-